Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
A clinical trial registry entry from Korea University describes a health screening-based registry for Metabolic Dysfunction-Associated Steat…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement [NA]
A clinical trial update describing a study that assesses cardiac function using MRI and echocardiography in patients with alcohol-related li…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Cardiac Dysfunction in Patients with Fatty Liver Disease
A recruiting clinical trial sponsored by the Post Graduate Institute of Medical Education and Research in Chandigarh evaluating cardiac dysf…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study [Phase 1]
Phase 1 pilot mechanistic study evaluating the effects of menopausal hormone replacement therapy on Metabolic Dysfunction Associated Steatot…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: MASLD Butyrate Supplementation Treatment Efficacy Review [Phase 3]
Phase 3 trial evaluating butyrate supplementation for MASLD is under efficacy review; no results or status details are provided in the updat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
An ongoing clinical study assessing the use of FibroScan to diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) in obe…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus
This clinical trial update describes a study evaluating whether serum adiponectin and resistin levels correlate with the degree of hepatic f…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD [NA]
Ongoing clinical trial evaluating TOTUM-448 for reducing liver fat and improving metabolic risk factors in MASLD, with current recruitment s…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
This document provides an update on the development of new non-invasive biomarkers for metabolic dysfunction-associated steatotic liver dise…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD
This study evaluates ultrasound-derived fat fraction as a noninvasive method to quantify hepatic steatosis in patients suspected of Metaboli…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases [NA]
A clinical study funded by Jinling Hospital in China is evaluating hyperbaric oxygen therapy for metabolic dysfunction-associated steatotic …
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial [NA]
A clinical trial evaluating endoscopic ultrasound shear wave elastography for assessing liver fibrosis in patients with MASLD is currently r…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin [EARLY_Phase 1]
An EARLY Phase 1 clinical trial from PGIMER Chandigarh evaluating dapagliflozin for metabolic dysfunction-associated steatotic liver disease…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Pattern of Cardiac Arrhythmia in Patients With MASLD
A clinical trial at Sohag University is studying patterns of cardiac arrhythmia in patients with MASLD and is currently recruiting participa…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Luminal Fructose Kinetics (MARTINI Study) [Phase 2]
Phase 2 trial MARTINI evaluating luminal fructose kinetics in metabolic dysfunction-associated steatotic liver disease is currently recruiti…
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Ketogenic Diet in MASLD-related cACLD [NA]
Clinical trial evaluating a ketogenic diet for MASLD-related compensated advanced chronic liver disease; recruitment has not yet started.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Global Research Initiative for Patients Screening on MASH
A clinical trial update shows recruitment is ongoing for the Global Research Initiative for Patients Screening on MASH, enrolling participan…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Investigating Myosteatosis in Steatotic Liver Diseases
Clinical trial update on investigating myosteatosis in steatotic liver diseases. Enrollment is by invitation.
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease [NA]
Clinical trial update describing a study targeting skeletal muscle to treat metabolic dysfunction-associated steatotic liver disease. The tr…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
A clinical trial is recruiting Hispanic patients with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) to analyze fecal micr…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD
Clinical trial evaluating whether serum pro-neurotensin can serve as a diagnostic biomarker for metabolic dysfunction-associated steatotic l…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD [NA]
A clinical trial evaluating whether high-intensity exercise rehabilitation improves liver function and insulin sensitivity in patients with …
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity [NA]
A clinical trial update describing a new approach to engage patients with steatotic liver disease in physical activity; the study is not yet…